p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment

SIMPLE SUMMARY: Acquired resistance to chemoradiotherapy is the common cause of relapse in cancer treatments. Although chemoradiotherapy often produces promising results early in treatment, most cancer patients develop resistance in the later stages and succumb to the disease. In this review, we att...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnaraj, Jayaraman, Yamamoto, Tatsuki, Ohki, Rieko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341282/
https://www.ncbi.nlm.nih.gov/pubmed/37444509
http://dx.doi.org/10.3390/cancers15133399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341282/
https://www.ncbi.nlm.nih.gov/pubmed/37444509
http://dx.doi.org/10.3390/cancers15133399

Ejemplares similares